Key Insights

Highlights

Treatment Research

10 treatments under study, led by Melphalan

Related Conditions

Often studied with 18 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00716066Phase 2Active Not Recruiting

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Showing all 1 trials

Research Network

Common Treatments

  • Melphalan1
  • Autologous Hematopoietic Stem Cell Transplantation1
  • Antithymocyte Globulin1
  • Etoposide1
  • Cytarabine1

Active Sponsors

  • Fred Hutchinson Cancer Center1

Top Investigators

Related Conditions

  • Cidp Transplant1
  • Ms Stem Cell Transplant1
  • Myasthenia Gravis1
  • Lambert Eaton Myasthenic Syndrome1
  • Neurologic Autoimmune Disease1

Activity Timeline